NEXT Financial Group, Inc - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 240 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$8,000
-20.0%
420
-4.3%
0.00%0.0%
Q3 2021$10,000
-9.1%
439
+4.5%
0.00%0.0%
Q2 2021$11,000
-15.4%
4200.0%0.00%0.0%
Q1 2021$13,000
-31.6%
4200.0%0.00%
-50.0%
Q4 2020$19,000
+35.7%
4200.0%0.00%0.0%
Q3 2020$14,000
+75.0%
420
-40.0%
0.00%
-50.0%
Q3 2018$8,0007000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders